arrow
W

Wilhelmus J. Kwanten

University of Antwerp
H指数:26
被引数:2,308

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Porto-sinusoidal vascular disorder-type lesions in patients with early fibrotic stages of metabolic dysfunction-associated steatotic liver disease

代谢功能障碍相关脂肪性肝病早期纤维化阶段患者的门-窦血管紊乱型病变

2026-01-010
OA
Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLD

使用非侵入性检测预测当代多中心队列中cACLD患者的肝功能失代偿

2025-11-040
PRE
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study
2024-12-012
PRE
Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD

肝静脉压力梯度预测MASLD患者肝功能失代偿和肝脏相关死亡率的风险

2024-11-014
OAAI
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease

铁死亡是代谢功能障碍相关的脂肪性肝病的靶向有害因素

2024-07-262
OAAI
Metabolic Dysfunction-Associated Fibrosis 5 (MAF-5) Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction

代谢功能障碍相关纤维化5 (MAF-5) 评分预测代谢功能障碍一般人群的肝纤维化风险和结果

2024-07-019
OA
Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis

使用机器学习模型评估代偿期肝硬化患者的门脉高压严重程度

2023-02-0116
OAAI
Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease
2022-10-0150
OAAI